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SV40 T antigen downregulates the expression of an important detoxification enzyme, glutathione S-transferase a (GSTa).
We show here that the target of this repression is a 14-bp element common to the human GSTA1 and GSTA2 promoters. This
element, which we have named TAGR, is also critical for high-level, constitutive expression from these promoters. The TAGR
element does not appear to contain a binding site for any transcription factor known to be present in fibroblasts, although
the TAGR element does resemble the binding site for the Ikaros transcription factor found in hematopoietic cells. We also
have identified a 47-amino-acid fragment of T antigen that includes amino acids 83–100 and 119–147, which is sufficient to
repress transcription from the GSTa promoter in transient transcription assays. Thus, GSTa repression does not require
binding of T antigen to pRb, p300, or p53, since the domains of T antigen required for binding these cellular proteins are
missing from this T antigen fragment. We show, however, that this fragment does bind to three cellular proteins with
approximate molecular weights of 54, 59, and 94 kDa. © 1998 Academic Press
We have discovered a novel function of SV40 T
antigen and the adenovirus E1A proteins: the ability to
downregulate the endogenous expression of an im-
portant detoxification enzyme, glutathione S-trans-
ferase a (GSTa) (Sompayrac, 1997). The glutathione
S-transferases (GSTs) are a family of enzymes that
catalyze the conjugation of glutathione with electro-
philic compounds, many of which can damage DNA.
These potential mutagens can be generated endog-
enously, as byproducts of normal cellular metabolism,
or may arise from exogenous sources that include
environmental carcinogens and drugs used for cancer
therapy. Once conjugated, these compounds are no
longer mutagenic, and because they are more water
soluble, they can be removed from the body by excre-
tion in the urine or bile (Sies and Ketterer, 1988). The
fact that glutathione S-transferases represent about
4% of the cytosolic protein in human liver cells under-
scores their importance in detoxification of endoge-
nous and exogenous mutagens (van Ommen et al., 1990).
Our working hypothesis is that by downregulating ex-
pression of GSTa in cells in which they establish a
persistent infection, tumor viruses such as adeno and
SV40 render these cells less able to detoxify carcino-
gens. This increased susceptibility to mutation, coupled
with abrogation of the p53 surveillance function, could
contribute to the initiation of or progression toward ma-
lignancy. Indeed, we have shown that decreased expres-
sion of GSTa in cells that produce SV40 T antigen cor-
relates with increased sensitivity to drugs such as
mechlorethamine, BCNU, and chlorambucil—drugs that
GSTa is known to detoxify (Sompayrac, 1997).
In humans, two a class GST genes that are expressed
in many different tissues and organs have been identi-
fied: GSTA1 and GSTA2 (Klone et al., 1992; Rohrdanz et
al., 1992; Rozen et al., 1992). These two genes are re-
sponsible for about 75% of the total GST expression in
the liver, a major organ involved in systemic detoxifica-
tion (van Ommen et al., 1990). Although subtly different,
the GSTA1 and GSTA2 promoters are identical in se-
quence between nucleotide 2169 and the transcription
start site (defined as 11) (Lo¨rper et al., 1996).
We had two goals in performing the experiments pre-
sented here. First, we wished to identify cis-acting reg-
ulatory elements of the GSTA1 promoter involved in re-
pression by SV40 T antigen. Second, we wanted to de-
lineate more precisely the domain of SV40 T antigen
required for this repression. We report here that a 47-
amino-acid fragment of T antigen that includes amino
acids 83–100 and 119–147 can repress GSTa expression
and that a 14-bp element common to the GSTA1 and
GSTA2 promoters is the target of repression by T antigen.
This target, which we call the TAGR (T antigen repres-
sion) element, is also critical for high-level, constitutive
expression from the GSTA1 and GSTA2 promoters.
1 To whom correspondence and reprint requests should be ad-
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RESULTS
A GSTa promoter element involved in transcriptional
repression by SV40 T antigen
To identify promoter elements involved in regulating
GSTa expression, we performed transient transfection
assays in which we transfected rat F111 cells with vari-
ous fragments of the human GSTA1 promoter linked to a
luciferase reporter gene. We included in these transfec-
tions either a plasmid that expresses SV40 large T anti-
gen or, as a control, the empty expression plasmid.
Beginning with a 1.3-kb promoter fragment (Lo¨rper et al.,
1996), we made deletions of increasing size from the 59
end. Figure 1a shows that when promoter constructs
were transfected together with the empty expression
plasmid, luciferase activities remained relatively con-
stant even when only 101 bases remained upstream of
the transcription start site. Likewise, when the same
promoter constructs were transfected together with the
T-antigen expression plasmid, we observed a relatively
consistent, 3-fold reduction in luciferase activity (Fig. 1b).
In contrast, when all GSTA1 promoter sequences 59 of
279 were deleted, there was a dramatic decrease in
constitutive promoter activity (Fig. 1a), and most down-
regulation by T antigen was also lost (Fig. 1b). Interest-
ingly, when we introduced a mutation into the 2151
promoter construct that changes nucleotide 286 from C
to G (Fig. 1c), we observed a decrease in T antigen-
mediated repression that was similar to that observed
when sequences upstream of nucleotide 279 were de-
leted (Fig. 1b), and constitutive expression decreased
about 30-fold (Fig. 1d). These results indicate that an
element between position 2102 and 279 is important for
both constitutive and repressible transcription of the
GSTa promoter and that within this element, the identity
of the nucleotide at position 286 is critical.
To define further the promoter sequences involved
in downregulation, we inserted three copies of the
region from 298 through 285 just upstream of a
minimal GSTA1 promoter (beginning at nucleotide
249) linked to the luciferase reporter gene. Insertion
of three copies of this fragment increased constitutive
expression over 100-fold (Fig. 1e) and restored repres-
sion by T antigen to the level observed with the 1.3-kb
promoter (Figs. 1b and 1f). These results confirm that
the 298 to 285 fragment includes promoter elements
involved in both constitutive and repressible transcrip-
tion. In these experiments, we also observed some
repression by SV40 T antigen of transcription from the
minimal GSTa promoter (Fig. 1f). Although slight, this
repression is reproducible and suggests that T anti-
gen may also interfere with the workings of the basal
transcription machinery.
Cellular proteins bind GSTa promoter fragments
in gel shift assays
Next, we used a 298 to 284 fragment in gel shift
assays to determine whether nuclear extracts from F111
cells contained proteins that could bind this fragment
and shift its mobility on acrylamide gels. Figures 2a and
2b (lane 2) show that the electrophoretic mobility of this
fragment is markedly reduced when the fragment is
incubated with cell extract before electrophoresis. A sim-
ilar set of shifted bands was observed with a slightly
smaller, 298 to 286 fragment (Fig. 2b, lane 3), indicating
that nucleotides 284 and 285 do not contribute to the
observed gel shift. In contrast, reducing the fragment
size by deleting four nucleotides at the 59 end to produce
a 294 to 286 fragment abolished the shifted bands (Fig.
2b, lane 1).
We also tested whether the 86C/G mutation, which has
such a dramatic effect on both constitutive and repress-
ible expression of the GSTa promoter in transient trans-
fection assays, would have a correspondingly dramatic
effect on the mobility of DNA–protein complexes in gel
shift assays. Figure 2b (lane 5) shows that introducing
the 86C/G mutation into the 298 to 286 oligonucleotide
abolishes the gel shift. These studies indicate that the
nucleotide at position 286 is crucial for both transcrip-
tion and gel shifting and strongly suggest that the com-
plexes observed in gel shift assays play a role in con-
trolling GSTa transcription.
p300 is probably not a component of the
TAGR–protein complexes
Moran and colleagues (Rikitake and Moran, 1992)
have shown that p300 binds specifically to the consen-
sus sequence, GGGAGTG. Intriguingly, this exact se-
quence is included in the 298 to 286 GSTa fragment
(Fig. 3), raising the possibility that p300 might be a
constituent of the complexes we observe in gel shift
assays. To test this, we performed assays in which we
added antibodies that recognize p300. Our expectation
FIG. 1. Relative luciferase activity of GST–luciferase reporter constructs. We transfected F111 cells with various GST–luciferase reporter constructs
together with an empty expression plasmid (a, d, and e) or a plasmid that expresses SV40 T antigen (b, c, and f). Fold repression was calculated by
dividing the luciferase activity measured in transfections with the empty expression plasmid by the activity with the T antigen expression plasmid.
In each construct, the number of base pairs remaining 59 of the transcription start site of the GSTA1 promoter is indicated by a negative number. The
33 promoter construct contains three copies of a 298 to 285 fragment positioned just 59 of a truncated GSTA1 promoter that has nucleotide 249
at its 59 end.
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was that if the shifted complexes included p300, they
might be super shifted by these antibodies. Figures 2c
and 2d show the results of experiments using four dif-
ferent antibodies. Although several of the antibodies af-
fected the amount of oligonucleotide probe shifted (an
effect we have observed with other, irrelevant antibod-
ies), in no case did we detect a mobility super shift. Of
course, these negative results are not conclusive be-
cause epitopes recognized by these antibodies might be
hidden in the shifted complexes. However, the fact that
three monoclonal antibodies and one polyclonal anti-
body preparation failed to give a super shift does sug-
gest that p300 is not part of the shifted complexes. As a
further test, we examined the ability of an oligonucleo-
tide, F593, to compete with the labeled 298 to 286
fragment for complex formation. Moran and colleagues
(Rikitake and Moran, 1992) have shown that F593 con-
tains a variant of the consensus p300 binding motif that
efficiently binds the p300 protein (Fig. 3a). We reasoned,
therefore, that if p300 binds directly to the labeled 298 to
286 fragment, excess cold F593 should compete for this
binding. Figure 2e shows that the F593 oligonucleotide
does not compete efficiently with the labeled 298 to 286
fragment under conditions in which a cold 298 to 286
oligonucleotide does compete. These results support the
conclusion that p300 is not a constituent of the com-
plexes we observe.
FIG. 3. GSTa promoter sequences. (a) Alignment of the 298 to 285
TAGR element with the F593 oligonucleotide, the p300 core binding
site, and an Ikaros binding site. (b) Sequence of GST–luciferase re-
porter plasmid between nucleotide 2101 of the GSTA1 promoter (rel-
ative to the transcription start site) and the point of fusion between the
GSTA1 promoter and the luciferase gene. The TATA box is underlined.
FIG. 2. Gel shift assays. We incubated nuclear extracts from F111 cells or from a derivative of the F111 line (FWT) that expresses SV40 large T
antigen together with various double-stranded oligonucleotides and subjected the mixtures to gel electrophoresis as described under Materials and
Methods. For clarity of presentation, the band corresponding to the unshifted oligonucleotide has been omitted from all except (a). (a) Labeled 298
to 284 oligonucleotide incubated with (lane 2) or without (lane 1) F111 extract. (b) Indicated oligonucleotides incubated with F111 extract (lanes 1–3
and 5) or FWT extract (lane 4). (c) 298 to 286 oligonucleotide incubated with F111 extract (lane 1) or F111 extract that had been preincubated with
anti-p300 antibodies (lanes 2 and 3). The identities and sources of these antibodies are given under Materials and Methods. Except as noted, we
used 2 ml of each antibody preparation. (d) Similar to (c) except that varying amounts of antibody (1, 2, or 4 ml) were used, as indicated. (e) Labeled
298 to 286 oligonucleotide incubated with F111 extract without or with a 10-fold molar excess of either cold F593 oligonucleotide or cold 298 to
286 nucleotide. (f) 298 to 286 oligonucleotide incubated with F111 extract without zinc chelator (lane 1), with zinc chelator (lane 2), or with zinc
chelator plus additional zinc chloride (lane 3).
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An Ikaros-like transcription factor may be involved
in T-antigen-mediated repression
We scanned the sequence of the 298 to 286 promoter
fragment and identified only one putative binding site for
a known transcription factor: a zinc-finger-containing fac-
tor called Ikaros (Fig. 3a) (Molnar and Georgopoulos,
1994). Because of this sequence similarity, we tested
whether the mobility shifts we observed were dependent
on the presence of zinc. Figure 2f (lanes 1 and 2) shows
that the gel shifts were abolished when 1,10-phenanthro-
line, a chelator of zinc ions, was included during incu-
bation of the 298 to 286 fragment with cell extracts. This
effect could be reversed by adding back zinc after incu-
bation with the chelator (Fig. 2f, lane 3). These results
suggest that a transcription factor which requires zinc for
binding may be involved in regulating GSTa expression.
It is unlikely, however, that the transcription factor is
Ikaros, since Ikaros expression appears to be limited to
hematopoietic cells (Molnar and Georgopoulos, 1994).
T antigen does not affect the mobility of DNA–protein
complexes in gel shift assays
To downregulate expression from the GSTa promoter,
SV40 T antigen might act directly by interacting with
proteins associated with the TAGR element. If so, we
would expect that T antigen would alter the mobilities of
the shifted bands seen with the 298 to 286 fragment. To
test this, we compared gel shifts obtained using extracts
prepared from F111 cells with shifts obtained using ex-
tracts from a derivative of the F111 line that expresses T
antigen. Figure 2b (lanes 3 and 4) shows that both
extracts gave shifted bands with similar mobilities. Al-
though in this particular experiment the relative intensi-
ties of lower and upper shifted bands were different
when extracts contained T antigen, this difference is not
likely to be significant because the relative intensities of
the upper and lower bands vary from experiment to
experiment (e.g., compare Figs. 2b, 2c, and 2f). The
finding that the presence of T antigen in cell lysates does
not alter the mobilities of shifted bands indicates that
SV40 T antigen does not interact directly with proteins
associated with the TAGR element.
The region of T antigen required for transcriptional
repression
To map the region of SV40 T antigen required to
repress transcription, we tested the ability of various T
antigen deletion mutants to downregulate transcription
of the triplicated 298 to 285 GSTa promoter construct
(33) in transient transfection assays. Figure 4 summa-
rizes the results of these experiments. First, a fragment
of T antigen extending from amino acids 1 to 147, but
lacking amino acids 101 through 118 (T147D2H), re-
presses transcription as strongly as does wild-type T
antigen. Thus, amino acids carboxy-terminal to amino
acid 147 of T antigen are not essential for downregula-
tion. This deleted carboxy-terminal region includes the
domains of T antigen required for binding to the tumor
suppressor protein, p53 (Schmeig and Simmons, 1988),
and to the p300 coactivator protein (Lill et al., 1997).
Moreover, amino acids 101 to 118, which are deleted in
the T147D2H antigen, include the domain required for
binding of T antigen to the Rb tumor suppressor protein
(Yaciuk et al., 1991). Therefore, we conclude that GSTa
downregulation by T antigen does not require binding to
p53, pRb, or p300.
To further delineate the region of T antigen required for
repression, we tested the ability of three more T antigen
deletion mutants to repress expression from the 33
FIG. 4. Luciferase assays with mutant T antigens. We transfected F111 cells with plasmids that express either wild-type SV40 T antigen (WT) or
various mutant T antigens together with a luciferase promoter construct that contains a triplication of the 298 to 285 fragment of the GSTA1 promoter
inserted 59 of a minimal GST promoter–luciferase reporter construct. Dark bars indicate regions of T antigen that are present in various SV40 mutant
T antigens. Numbers above the bars indicate the first or last amino acids that are included in the protein fragments. Fold repression is the ratio of
luciferase reporter activity in transfections with the empty expression plasmid divided by the luciferase activity with expression plasmids that include
coding sequences for the various T antigens. Each value is the average of the results of at least four different experiments.
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promoter. A mutant T atigen that includes only amino
acids 83 to 147 significantly represses expression from
the 3X reporter, and a T antigen fragment including only
amino acids 83 to 100 and 119 to 147 also represses
expression (Fig. 4). Although the latter T antigen down-
regulates expression only about 1.8-fold (average of six
experiments), this is still above background in these
assays. Finally, we tested a mutant T antigen that in-
cludes only amino acids 119 through 147. This mutant
gives no repression above background (Fig. 4). Taken
together, these results demonstrate that the T antigen
repression domain is bounded by amino acids 83 and
147 and does not require amino acids 101 to 118.
We have attempted to derive stably transfected cell
lines that express levels of the 83/147 and 83/147D2H
proteins comparable to the levels we observe in cells
that express the T147D2H mutant T antigen, but we have
not been successful. Although we do observe nuclear
fluorescence when cells that stably express either the
83/147 or 83/147D2H antigens are stained with anti-T
antibodies, this fluorescence is rather weak compared to
the strong nuclear fluorescence we typically observe in
cell lines that stably express T147D2H. Based on our
previous experience with mutant T antigens, we suspect
that the 83/147 and 83/147D2H proteins are less stable
than the T147D2H protein. This may explain why we
observe reduced repression in transient transfection ex-
periments with these proteins (Fig. 4). Unfortunately, we
know of no antibody that recognizes the region of T
antigen between amino acids 119 and 147, so we have no
data on the relative stability of this protein fragment.
Thus, we must leave open the possibility that the mini-
mum domain required for repression lies between amino
acids 119 and 147.
The domain of T antigen required for repression of
the GSTa promoter binds to three cellular proteins
Our experiments define a 47-amino-acid fragment of
T antigen that is sufficient to repress GSTa transcrip-
tion. Because many functions of T antigen involve
interactions between T antigen and cellular proteins,
we used a GST-83/147D2H fusion protein as ligand for
affinity chromatography to test whether there might be
cellular proteins that bind this fragment. The silver-
stained gels in Figs. 5a and 5b show that there are
three proteins in HeLa cell extracts that bind to the
GST-83/147D2H fusion protein (lane 2), but not to the
GST tag alone (lane 1). These proteins have approxi-
mate molecular weights of 54, 59, and 94 kDa. We
repeated these experiments with another fusion pro-
tein in which the GST tag was fused to amino acids
119 to 147. Figure 5b shows that the same three pro-
teins that bind to the 47-amino-acid fragment (lane 2)
also bind to amino acids 119 to 147 (lane 3). Finally, we
repeated this experiment with a fusion protein that
includes only amino acids 130 to 147 of T antigen, but
we detected no cellular proteins that bind to this
fragment (Fig. 5b, lane 4). It should be noted that this
T antigen fragment does not contain the sequences
required for nuclear localization.
FIG. 5. Affinity chromatography. We used T antigen–GST fusion
proteins as ligands for affinity chromatography to detect proteins in
HeLa cell extracts that bind to various fragments of T antigen. (a)
Silver-stained gel of chromatography with GST protein alone (lane 1) or
GST–83/147D2H fusion protein (lane 2). (b) Chromatography with GST
protein alone (lane 1), GST–83/147D2H fusion protein (lane 2), GST–
119/147 fusion protein (lane 3), or GST–130/147 fusion protein (lane 4).
Brackets labeled “GST” indicate bands due to GST or GST fusion
proteins that eluted from the column.
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DISCUSSION
In earlier experiments, we showed that SV40 T antigen
can downregulate the endogenous expression of rat and
human glutathione S-transferase a genes, and we pos-
tulated that this downregulation might render SV40-in-
fected cells more vulnerable to mutagens that GSTa
normally would detoxify. We proposed that by this mech-
anism, T antigen might act as a cocarcinogen to increase
the susceptibility of these cells to cancer-causing muta-
tions. In support of this idea, we showed that rat cells
which express SV40 T antigen are more susceptible to
killing by toxic drugs such as mechlorethamine, BCNU,
and chlorambucil (Sompayrac, 1997).
Transient transfection assays had shown that two hu-
man GSTa promoters, GSTA1 and GSTA2, contain both
positive and negative regulatory elements between
about 1.3 kb and 150 nucleotides upstream of their tran-
scriptional start sites (Lo¨rper et al., 1996). We now report
that there is also a major regulatory element contained
between nucleotides 299 and 284. This 14-bp element,
which we have named TAGR, is present in both the
GSTA1 and GSTA2 promoters and is important not only
for constitutive expression, but also for repression by
SV40 T antigen. In transient transfection assays, deletion
of the TAGR element reduced constitutive expression
about 30-fold and severely inhibited T antigen’s ability to
repress transcription. When a triplication of this element
was inserted into a minimal GSTa promoter, normal
levels of constitutive expression were restored, and re-
pression by T antigen returned to levels observed with a
1.3-kb GSTA1 promoter construct. These results with
F111 rat cells are consistent with recent findings that the
region of the GSTa promoter between 296 and 275
contains elements that are important for high-level, con-
stitutive expression in human cells (Lo¨rper et al., 1998).
We also used gel shift assays to demonstrate that
proteins contained in a nuclear extract from F111 fibro-
blasts associate with the TAGR element and shift its
mobility on acrylamide gels. Because binding of cellular
proteins to the TAGR element requires zinc, a zinc-re-
quiring transcription factor is likely to be involved. Stud-
ies with anti-p300 antibodies and an oligonucleotide
known to bind p300 suggest that this cellular coactivator
protein is not part of the shifted complexes, even though
the TAGR element contains a canonical p300 binding
site. A single C to G change at position 286 that dra-
matically reduces transcription from the GSTa promoter
also abolishes protein–TAGR element complexes in gel
shift assays. Therefore, it is likely that these complexes
are important for transcription from the GSTa promoter.
We also demonstrated that a 47-amino-acid fragment
of T antigen which includes amino acids 83 to 100 plus
119 to 147 is sufficient to repress transcription. This
fragment lacks the domains of T antigen required for
binding to three cellular proteins: pRb, p53, and p300.
Earlier, we had demonstrated that an SV40 mutant which
expresses only amino acids 1 to 100 plus 119 to 147 can
repress endogenous GSTa expression and that SV40
small t antigen is not required for repression (Sompay-
rac, 1997). Therefore, the transient transfection studies
presented here recapitulate the results of our earlier
experiments on endogenous expression and extend
these findings by demonstrating that the first exon of
SV40 T antigen (aa 1–82) is not required for GSTa down-
regulation.
Although a number of cellular genes whose expres-
sion is downregulated by SV40 T antigen have been
identified, the regions of T antigen involved have been
mapped for only three of them. First, Livingston and
colleagues (Wang et al., 1994) reported that the amino-
terminal 82 amino acids of SV40 large T antigen can
inhibit c-fos expression in transient transfection assays.
Second, Kao et al. (1998) observed that the N-terminal
178 amino acids of T antigen are sufficient to repress
endogenous expression of the HER-2/neu oncogene,
and Matin and Hung (1993) showed that HER2/neu re-
pression does not require binding of T antigen to pRb.
Finally, we demonstrated that endogenous expression of
the a subunit of type XI procollagen is downregulated in
cells that express only the N-terminal 147 amino acids of
large T antigen (Sompayrac et al., 1996).
The region of T antigen identified in the present study
(aa 83–100 plus 119–147) includes the T antigen nuclear
localization signal (aa 126 to 132) (Kalderon et al., 1984).
In addition, Wildeman and colleagues (Coulombe et al.,
1992) have noted that this region of T antigen is rich in
acidic amino acids and therefore may function as an
acidic activation domain. Indeed, we find that amino
acids 83 to 100 plus 119 to 147 can activate certain yeast
promoters in a two-hybrid assay (L. Sompayrac, unpub-
lished). To our knowledge, no other activities have been
ascribed to the 83–100/119–147 region of T antigen.
Therefore, our current studies identify a previously un-
recognized function of this region of T antigen: the ability
to repress transcription.
T antigen itself does not appear to be a component of
the protein–oligonucleotide complexes we observe in
gel shift assays, because the mobilities of these com-
plexes are unchanged when cell extracts contain T an-
tigen. This indicates that T antigen does not interact
directly with proteins that are associated with the TAGR
element and suggests an indirect mechanism for T-anti-
gen-mediated repression. It is possible, for example, that
T antigen modifies the activity of a transcription factor
that regulates GSTa transcription through the TAGR ele-
ment. Alternatively, T antigen might bind to the minimal
transcription complex and interrupt a contact between
this complex and proteins associated with the TAGR
element. Our finding that T antigen can repress tran-
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scription from a minimal GSTa promoter, albeit weakly,
together with the observations of others that T antigen
can bind to the TATA box binding protein (Gruda et al.,
1993; Martin et al., 1993), indicates that T antigen may be
properly positioned to interrupt communication between
upstream factors and the basal transcriptional machin-
ery. Indeed, the region of T antigen we have identified as
being important for repression overlaps the region of T
antigen shown to be involved in binding the TATA box
binding protein (Gruda et al., 1993; Johnston, et al., 1996).
Using T antigen–GST fusion proteins, we detected three
cellular proteins that bind the 47-amino-acid, 83/147D2H
fragment. Because this fragment includes the sequences
required for nuclear localization, we suspect that the two
larger proteins with approximate molecular weights of 59
and 94 kDa may be the 58- to 60-kDa a and 90- to 97-kDa
b subunits of the importin protein required for nuclear
transport of T antigen (Kalderon et al., 1984; Nigg, 1997).
Although the identity of the 54-kDa protein that binds the
83/147D2H fragment remains to be determined, it is possi-
ble that repression of the GSTa promoter by T antigen is
mediated through binding to this protein. There is prece-
dent for this idea, of course: T antigen is known to modulate
the expression of other cellular genes by binding to pro-
teins such as p53 and pRb.
What are the practical implications of these findings?
Frequently, when malignancies are treated with antican-
cer drugs, a subpopulation of the cancer cells develops
resistance to killing by these drugs. This acquired resis-
tance can represent a significant problem in cancer
therapy. There are several mechanisms responsible for
acquired resistance, and one of them involves detoxifi-
cation of chemotherapeutic drugs by GSTs. Indeed, in-
creased GSTa expression has been shown to decrease
sensitivity to a number of anticancer drugs, including
adriamycin, melphalan, chlorambucil, cisplatin, and
BCNU (Black et al., 1990; Evans et al., 1987; Puchalski
and Fahl, 1990). We have identified a 14-bp element in
GSTa promoters that is important for high-level GSTa
expression and a 47-amino-acid domain of T antigen that
represses expression from the human GSTA1 and GSTA2
promoters. This information may be useful in designing




The GSTA1–luciferase plasmids called 21302, 21000,
2726, 2390, and 2151 in this work have been described
previously and were originally called p5.3/1.302luc, etc.
(Lo¨rper et al., 1996). We used PCR-based strategies to
introduce deletions into the 21302 promoter to make
constructs 2101 and 279 and to produce promoter con-
structs 286C/G and 33. The parental plasmid, p5.3/1302
luc, was constructed by cloning a fragment of the GSTA1
promoter, which extends from a BamHI site at position
21302 relative to the transcription start site to a HindIII
site just beyond the transcription start site, between the
BamHI and HindIII sites of the promoterless, luciferase
reporter vector, pXP2 (Nordeen, 1988). The SV40 expres-
sion plasmid, SRT147NS, has been described previously
(Sompayrac and Danna, 1989). It contains a cDNA for
SV40 large T antigen harnessed to a modified SV40 early
promoter (Takebe et al., 1988). We used SRT147NS and a
PCR-based strategy to construct plasmids that express
deleted versions of T antigen (83/147, 83/147D2H, and
119/147). We used pGEX2TKN (a kind gift from Dr. Jim
Goodrich) and a PCR-based strategy to construct plas-
mids that express GST–T antigen fusion proteins under
the control of the IPTG-inducible, tac promoter.
We used the following antibodies in gel shift assays:
monoclonal antibodies NM1 (called Ab3 herein) and NM11
(called Ab1) and rabbit polyclonal antibody ap300 (called
Ab4), which were kind gifts from Dr. Betty Moran (Dallas et
al., 1997), and monoclonal RW128 from UBI (called Ab2),
which was generously provided by Dr. Jim Cook.
Transient transfection assays
Frequently, transient transfection assays are normal-
ized for transfection efficiency by cotransfecting with a
control plasmid (e.g., b-galactosidase) whose expres-
sion level can be quantitated. However, we and others
have observed that it is virtually impossible to find a
control plasmid whose expression is not affected by
SV40 T antigen (Gruda et al., 1993). Because we planned
to use various mutant forms of T antigen that might or
might not include domains which modulate control pro-
moter expression, we decided not to normalize our tran-
sient transfection assays. Rather, we chose to pass each
transfected culture to two duplicate cultures. We then
used one culture to assay lucerferase activity and the
other to quantitate transfection efficiency by using South-
ern blotting to “count” the number of ampicillin genes that
were successfully transfected. We eliminated from con-
sideration any transfections in which the ratio of the
number of ampicillin genes counted in the transfection
with the control plasmid (which does not express T
antigen) to the number of ampicillin genes counted in the
transfection with a T-antigen-expressing plasmid varied
by more than a factor of 1.5 from the calculated value.
Each data point is the average of at least four transfec-
tions that passed this test.
We used calcium phosphate to transfect subconflu-
ent monolayers of F111 rat cells growing in 35-mm
dishes. For each transfection, we used a total of 6 mg
of plasmid DNA that included 1.5 mg of a GSTA1–
luciferase reporter plasmid, 2.25 mg of an expression
plasmid that encodes either wild-type or mutant SV40
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T antigen, and 2.25 mg of pUC19 DNA. To control for
sequestration of transcription factors by the promoter
of the T antigen expression plasmid, we performed
parallel transfections in which we used equal molar
amounts of the expression plasmid without T-antigen-
coding sequences. In these control transfections, we
adjusted the amount of pUC19 DNA to make the total
amount of DNA in each transfection 6 mg. Four hours
after transfection, we shocked the cultures with 15%
glycerol, and about 16 h after transfection, we tryp-
sinized the cells and plated an equal number of cells
onto two 60-mm dishes. About 40 h posttransfection,
we used the Promega luciferase assay system to lyse
the cells on one of these plates. Luciferase assays
were performed according to the manufacturer’s spec-
ifications, and luciferase activity was measured with a
luminometer.
We washed the second (duplicate) plate from each
transfection with PBS and used the method of Hirt (1967)
to prepare plasmid DNA. We blotted each DNA sample in
duplicate onto a nylon filter and hybridized the filter with
a 32P-labeled probe that recognizes sequences within
the ampicillin gene that is present in all our plasmids.
We used a phosphoimager to quantitate the relative
amounts of radioactivity that hybridized to each DNA
sample.
Gel shift assays
To prepare nuclear extracts, we harvested two slightly
subconfluent 100-mm dishes of F111 rat cells (about 3 3
106 total cells) by washing once on ice with 2 ml per dish
of cold ILB (20 mM HEPES (7.9), 300 mM sucrose, 10 mM
KCl, 1.5 mM MgCl2), aspirating both dishes completely,
and adding 1.2 ml of cold LB (1 mM PMSF, 0.01 mg/ml
aprotinin, 1 mM DTT, 0.5% NP40–made up in ILB) to one
dish. Our stock solution of PMSF was 333 mM in ethanol,
and our stock solution of aprotinin was 2 mg/ml in .01 M
HEPES (7.9). We policed the cells off these dishes into a
microfuge tube, vortexed the cell lysate for 10 s, and
returned the tube to ice for 20 min. We spun the lysate at
6000 rpm for 2 min, discarded the supernatant, spun
again briefly, and discarded the last of the supernatant.
We vortexed 5 s to resuspend the nuclear pellet in 50 ml
of NEB (20 mM HEPES (7.9), 300 mM sucrose, 420 mM
NaCl, 1.5 mM MgCl2, 0.5% NP40, 1 mM PMSF, 0.01 mg/ml
aprotinin), to which the protease inhibitors had been
added just prior to use. We kept the tube on ice for an
additional 30 min, spun it at full speed for 5 min at 4°C,
and removed the supernatant to a fresh tube. We added
glycerol to a final concentration of 10% and stored the
extract in aliquots at 270°C. The protein concentration
of extracts prepared in this way was about 2.5 mg/ml.
The following oligonucleotides were annealed for use in
these experiments: 98/86, 59GATCGTGTGGGAGTGGC39
and 59GATCGCCACTCCCACAC39; 94/86, 59GATCGGGAGT-
GGC39 and 59GATCGCCACTCCC39; 98/84, 59GATCGTGTG-
GGAGTGGCTT39 and 59GATCAAGCCACTCCACAC39; F593,
59CTGTTTAGGGACTGCATCAA39 and 59TTGATGCAGTCC-
CTAAACAG-39.
For standard gel shift assays, we combined on ice
about 5 3 103 cpm of gel-purified probe (labeled with
Klenow DNA polymerase and [32P]dCTP) with about 5 mg
of nuclear protein extract in 20 ml of BB (20 mM HEPES
(7.9), 0.1 M KCl, 0.1 mM EDTA, 2% glycerol, 0.1 mg/ml BSA,
5 mg/ml boiled, sonicated salmon sperm DNA, 0.1%
NP40, 1 mM DTT). We kept this mixture on ice for 30 min,
added loading dye, and subjected the mixture to electro-
phoresis on a 5% acrylamide gel run at room tempera-
ture in 1
2
3 TBE buffer. We dried the gel and visualized the
bands by autoradiography.
For experiments with the zinc chelator 1,10-phenanth-
roline, we modified the standard gel shift conditions as
follows: We omitted the labeled probe from the initial
incubation mixture, but included 1,10-phenanthroline
(stock solution is 13 mM in 50% ethanol) to a final con-
centration of 1 mM. After the mixture had stood 10 min on
ice, we added zinc to some samples to a final concen-
tration of 0.2 mM and continued the incubation for 5 min.
Then we added the probe and continued the incubation
on ice for 15 min before loading the samples onto the gel.
For experiments in which we used cold oligonucleo-
tides to compete with labeled nucleotides for binding, we
omitted the labeled probe from the initial incubation
mixture and added the unlabeled, competitor double-
stranded oligonucleotide instead. After a 30-min incuba-
tion on ice, we added the labeled probe and continued
the incubation for 30 min on ice.
For super shifting experiments, we omitted the labeled
probe from the initial reaction mix, but added the antibody.
After 15 min at room temperature, we added the labeled
probe and continued the incubation for 30 min on ice.
GST protein–protein interaction assay
We used a slight modification of the procedure of
Kaelin et al. (1991). We washed the HeLa cells on one
slightly subconfluent 100-mm dish once with cold PBS,
added 1.2 ml of cold PBS to the dish, and policed the
cells into a microfuge tube. We pelleted the cells by
spinning for 1 min at 10,000 rpm, washed the pellet twice
by vortexing with 1 ml of cold PBS, and resuspended the
cell pellet in 150 ml of cold PLB (50 mM Tris (8.0), 120 mM
NaCl, 0.5% NP40, 1 mM PMSF, 0.01 mg/ml aprotinin) by
vortexing. After 30 min on ice, the sample was spun at
full speed for 15 min at 4°C, and the supernatant re-
moved to a fresh tube.
We prepared glutathione–Sepharose 4B beads as rec-
ommended by the manufacturer (Pharmacia 27-4570-01)
except that after washing, we resuspended the beads in
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WB (20 mM Tris(8.0), 100 mM NaCl, 1 mM EDTA, 0.5%
NP40) that contained 0.5% nonfat dried milk (NFDM). We
prepared these beads fresh every few weeks and stored
them at 4°C between experiments.
To preclear the HeLa cell lysate, we added 20 ml of
washed glutathione–Sepharose beads and incubated
the mixture at 4°C for 1 h with gentle mixing. We spun the
mixture for 5 s in a microfuge with a horizontal head,
removed the supernatant to a new tube, and discarded
the beads.
We prepared GST–T antigen fusion proteins as fol-
lows: We diluted overnight cultures of bacteria trans-
fected with GST–T antigen expression plasmids 1:10 into
fresh 2YTA medium containing ampicillin and incubated
the bacteria for about 75 min at 37°C until the OD600 was
between 0.6 and 0.8. We then added IPTG to a final
concentration of 0.1 mM and continued the incubation for
an additional 2 h at 37°C. We added 1.5 ml of the bacteria
to a microfuge tube, spun the tube for 5 s, discarded the
supernatant, and added 300 ml of cold PBS to the pellet
on ice. After vortexing to resuspend the pellet, we soni-
cated the bacteria for 10 s, spun them for 5 min at 4°C,
transferred the supernatant to a fresh microfuge tube,
and added 20 ml of washed glutathione–Sepharose
beads (prepared as described above). We incubated the
bacterial lysate with the beads for 5 min at room tem-
perature with gentle mixing, washed the beads twice
with 100 ml of WB that contained 0.5% NFDM, removed
the supernatant, and added the precleared HeLa cell
lysate. We incubated the lysate/bead mixture for 1 h at
4°C with gentle mixing, washed the beads five times with
100 ml of WB (without NFDM), and eluted the bound
proteins for 10 min at room temperature with 35 ml of WB
that contained NaCl at a final concentration of 1M.
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